ICPT   $19.01  0.26% Market Closed

Intercept Pharmaceuticals Inc
Total Cash 322.71M
totalCashPerShare 7.716
EBITDA -54.72M
Total Debt 223.86M
quickRatio 3.922
currentRatio 4.221
Total Revenue 317.68M
debtToEquity 311.582
Revenue/Share 7.62
ROA -0.0723
ROE -0.64023
grossProfits 284.73M
freeCashflow -42.40M
operatingCashflow -63.02M
earningsGrowth
revenueGrowth 0.144
grossMargins 0.99801004
ebitdaMargins -0.17224
operatingMargins 0.018480001
profitMargins -0.19393998
enterpriseValue 695.84M
forwardPE 8.878504
floatShares 34.49M
sharesOutstanding 41.83M
sharesShort 10.14M
sharesShortPriorMonth 9.43M
dateShortInterest
sharesPercentSharesOut 0.24%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.81%
Short Ratio help_outline 5.54%
shortPercentOfFloat 0.25%
impliedSharesOutstanding
bookValue 1.718
Price To Book help_outline 11.06
earningsQuarterlyGrowth
netIncomeToCommon -57.47M
trailingEps -1.09%
forwardEps 2.14%
enterpriseToEbitda -12.72
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.09 4Q 2023
institutionsCount 219
lastUpdated Jan. 6, 2024, 3:30 a.m.